Skip to Main Content

Author Details

Azza Shoaibi
Janssen Pharmaceutical Research and Development
2010
32
14
PMIDPaper TitleJournal TitlePublished Year
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
38028730Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network.JAMIA Open2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
36826399Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational study.J Am Med Inform Assoc2023
38028730Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network.JAMIA Open2023
37034358Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study.EClinicalMedicine2023
35094685Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.BMC Med Res Methodol2022
35653017Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Drug Saf2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
35094685Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network.BMC Med Res Methodol2022
35653017Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study.Drug Saf2022
36188566International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients.Front Pharmacol2022
33367863Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.Rheumatology (Oxford)2021
35727911Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.BMJ2021
33791740Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.medRxiv2021
33661754Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study.JMIR Med Inform2021
33982938Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients.Am J Gastroenterol2021
33651368Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.Drug Saf2021
33367863Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study.Rheumatology (Oxford)2021
35727911Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.BMJ2021
33791740Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study.medRxiv2021
33651368Comparative Risk Assessment of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants: A Network Study Across Four Observational Databases in the USA.Drug Saf2021
33661754Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study.JMIR Med Inform2021
33982938Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients.Am J Gastroenterol2021
32864627Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.Lancet Rheumatol2020
32864627Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study.Lancet Rheumatol2020
33024121Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.Nat Commun2020
33024121Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study.Nat Commun2020
30484904A multivariate discrete failure time model for the analysis of infant motor development.Stat Med2019
30484904A multivariate discrete failure time model for the analysis of infant motor development.Stat Med2019
30782735Longitudinal associations of gross motor development, motor milestone achievement and weight-for-length z score in a racially diverse cohort of US infants.BMJ Open2019
30782735Longitudinal associations of gross motor development, motor milestone achievement and weight-for-length z score in a racially diverse cohort of US infants.BMJ Open2019
29355939Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Int J Cancer2018
30019385Household chaos during infancy and infant weight status at 12 months.Pediatr Obes2018
30474076Research participation preferences as expressed through a patient portal: implications of demographic characteristics.JAMIA Open2018
30474075The association between method of solicitation and patient permissions for use of surplus tissues and contact for future research.JAMIA Open2018
29355939Inflammatory potential of diet and risk of pancreatic cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.Int J Cancer2018
30019385Household chaos during infancy and infant weight status at 12 months.Pediatr Obes2018
30474076Research participation preferences as expressed through a patient portal: implications of demographic characteristics.JAMIA Open2018
30474075The association between method of solicitation and patient permissions for use of surplus tissues and contact for future research.JAMIA Open2018
27699819Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer.Prostate2017
28441388A population-based approach for implementing change from opt-out to opt-in research permissions.PLoS One2017
27699819Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer.Prostate2017
28441388A population-based approach for implementing change from opt-out to opt-in research permissions.PLoS One2017
26878275Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.Int J Cardiol2016
26878275Contrasting cardiovascular mortality trends in Eastern Mediterranean populations: Contributions from risk factor changes and treatments.Int J Cardiol2016
26611771The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Ann Epidemiol2016
26611771The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.Ann Epidemiol2016
24879318Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries.Int J Public Health2015
24879318Priority setting for the prevention and control of cardiovascular diseases: multi-criteria decision analysis in four eastern Mediterranean countries.Int J Public Health2015
  • 1 - 50 of 64

Recommended Authors

Feinberg School of Medicine, Northwestern University
Career Start Year 2014
Number of shared co-authors 0
Center for Clinical Investigation, Brigham and Women's Hospital
Career Start Year 2014
Number of shared co-authors 0
Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia
Career Start Year 2014
Number of shared co-authors 0
University of Virginia
Career Start Year 2013
Number of shared co-authors 0
University of California los angeles
Career Start Year 2013
Number of shared co-authors 0
USA Tempus Labs Inc.
Career Start Year 2012
Number of shared co-authors 18
Vanderbilt University Medical Center
Career Start Year 2011
Number of shared co-authors 0
Department of Health Services, Brown University School of Public Health
Career Start Year 2010
Number of shared co-authors 0
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2009
Number of shared co-authors 5
University of Pennsylvania, Perelman School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Harvard Medical School and Harvard Pilgrim Health Care Institute
Career Start Year 2006
Number of shared co-authors 6
Ralph H. Johnson Veterans Affairs Healthcare System.
Career Start Year 2004
Number of shared co-authors 0
Harvard T.H. Chan School of Public Health
Career Start Year 2004
Number of shared co-authors 1
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Institute of Health Policy Management and Evaluation, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Hospital of the University of Pennsylvania
Career Start Year 2003
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 3
Pennsylvania State University-Milton S. Hershey Medical Center
Career Start Year 2001
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 1
Vanderbilt University Medical Center.
Career Start Year 1997
Number of shared co-authors 1
Stanford University
Career Start Year 1997
Number of shared co-authors 2
Baylor College of Medicine
Career Start Year 1997
Number of shared co-authors 0
University of Washington
Career Start Year 1992
Number of shared co-authors 2
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 3
Columbia University.
Career Start Year 1990
Number of shared co-authors 23
Harvard Medical School
Career Start Year 1988
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 1988
Number of shared co-authors 5
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 1

Collaborators

Janssen Pharmaceutical Research and Development LLC
Co-authored papers 14
University of California los angeles
Co-authored papers 12
Columbia University Irving Medical Center
Co-authored papers 11
Columbia University
Co-authored papers 11
Erasmus University Medical Center
Co-authored papers 11
University of Oxford
Co-authored papers 10
Erasmus University Medical Center
Co-authored papers 10
University of Dundee
Co-authored papers 9
OHDSI Center at The Roux Institute, Northeastern University
Co-authored papers 8
University of Utah Health
Co-authored papers 8
University of Gothenburg
Co-authored papers 7
Janssen Pharmaceutical Research and Development
Co-authored papers 7
University of Utah
Co-authored papers 7
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 6
Yonsei University College of Medicine
Co-authored papers 6
Riyadh Elm University
Co-authored papers 6
Janssen Pharmaceutical Research & Development
Co-authored papers 6
Erasmus University Medical Center
Co-authored papers 5
Co-authored papers 5
Erasmus University Medical Center
Co-authored papers 5
Columbia University Irving Medical Center
Co-authored papers 5
Primary Care Research Institute Jordi Gol, Universitat Autonoma de Barcelona
Co-authored papers 5
Copenhagen University Hospital - Rigshospitalet
Co-authored papers 5
University of Sao Paulo
Co-authored papers 5
University of California los angeles
Co-authored papers 5
Ajou University Graduate School of Medicine
Co-authored papers 4
University of Oxford
Co-authored papers 4
University of Oxford
Co-authored papers 4
Co-authored papers 4
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Co-authored papers 4